152 related articles for article (PubMed ID: 1899057)
1. Identification of an aflatoxin G1-serum albumin adduct and its relevance to the measurement of human exposure to aflatoxins.
Sabbioni G; Wild CP
Carcinogenesis; 1991 Jan; 12(1):97-103. PubMed ID: 1899057
[TBL] [Abstract][Full Text] [Related]
2. Chemical and physical properties of the major serum albumin adduct of aflatoxin B1 and their implications for the quantification in biological samples.
Sabbioni G
Chem Biol Interact; 1990; 75(1):1-15. PubMed ID: 2114222
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of the major serum albumin adduct formed by aflatoxin B1 in vivo in rats.
Sabbioni G; Skipper PL; Büchi G; Tannenbaum SR
Carcinogenesis; 1987 Jun; 8(6):819-24. PubMed ID: 3111739
[TBL] [Abstract][Full Text] [Related]
4. The aflatoxin-lysine adduct quantified by high-performance liquid chromatography from human serum albumin samples.
Sabbioni G; Ambs S; Wogan GN; Groopman JD
Carcinogenesis; 1990 Nov; 11(11):2063-6. PubMed ID: 2121383
[TBL] [Abstract][Full Text] [Related]
5. Detectable levels of serum aflatoxin B1-albumin adducts in the United Kingdom population: implications for aflatoxin-B1 exposure in the United Kingdom.
Turner PC; Dingley KH; Coxhead J; Russell S; Garner CR
Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):441-7. PubMed ID: 9610795
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of methods for quantitation of aflatoxin-albumin adducts and their application to human exposure assessment.
Wild CP; Jiang YZ; Sabbioni G; Chapot B; Montesano R
Cancer Res; 1990 Jan; 50(2):245-51. PubMed ID: 2104776
[TBL] [Abstract][Full Text] [Related]
7. Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans.
Wild CP; Hasegawa R; Barraud L; Chutimataewin S; Chapot B; Ito N; Montesano R
Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):179-89. PubMed ID: 8833618
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis and chronic dosimetry of the aflatoxin B1 plasma albumin adduct Lys-AFB1 in rats by isotope dilution mass spectrometry.
Scholl PF; McCoy L; Kensler TW; Groopman JD
Chem Res Toxicol; 2006 Jan; 19(1):44-9. PubMed ID: 16411655
[TBL] [Abstract][Full Text] [Related]
9. Comparison of aflatoxin B1 and aflatoxin G1 binding to cellular macromolecules in vitro, in vivo and after peracid oxidation; characterisation of the major nucleic acid adducts.
Garner RC; Martin CN; Smith JR; Coles BF; Tolson MR
Chem Biol Interact; 1979 Jun; 26(1):57-73. PubMed ID: 466744
[TBL] [Abstract][Full Text] [Related]
10. Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1.
Gan LS; Skipper PL; Peng XC; Groopman JD; Chen JS; Wogan GN; Tannenbaum SR
Carcinogenesis; 1988 Jul; 9(7):1323-5. PubMed ID: 3133131
[TBL] [Abstract][Full Text] [Related]
11. Comparison of rates of enzymatic oxidation of aflatoxin B1, aflatoxin G1, and sterigmatocystin and activities of the epoxides in forming guanyl-N7 adducts and inducing different genetic responses.
Baertschi SW; Raney KD; Shimada T; Harris TM; Guengerich FP
Chem Res Toxicol; 1989; 2(2):114-2. PubMed ID: 2519710
[TBL] [Abstract][Full Text] [Related]
12. Enzyme immunoassay for aflatoxin B1-lysine adduct and its validation.
Sujatha N; Suryakala S; Rao BS
J AOAC Int; 2001; 84(5):1465-74. PubMed ID: 11601466
[TBL] [Abstract][Full Text] [Related]
13. Immunological detection of aflatoxin B1-DNA adducts formed in vivo.
Hsieh LL; Hsu SW; Chen DS; Santella RM
Cancer Res; 1988 Nov; 48(22):6328-31. PubMed ID: 3141043
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the assay of AFB1-albumin adducts using proteolysis products in ELISA.
Olubuyide IO; Makarananda K; Judah DJ; Neal GE
Int J Cancer; 1991 May; 48(3):468-72. PubMed ID: 1904051
[TBL] [Abstract][Full Text] [Related]
15. Excretion of an aflatoxin-guanine adduct in the urine of aflatoxin B1-treated rats.
Bennett RA; Essigmann JM; Wogan GN
Cancer Res; 1981 Feb; 41(2):650-4. PubMed ID: 6778611
[TBL] [Abstract][Full Text] [Related]
16. Simplified Synthesis and Stability Assessment of Aflatoxin B
Renaud JB; Walsh JP; Sumarah MW
Toxins (Basel); 2022 Jan; 14(1):. PubMed ID: 35051035
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of mercapturic acid (N-acetyl-L-cysteine)-aflatoxin B1 adduct and its quantitation in rat urine by an enzyme immunoassay.
Nayak S; Tanuja P; Sashidhar RB
J AOAC Int; 2009; 92(2):487-95. PubMed ID: 19485208
[TBL] [Abstract][Full Text] [Related]
18. Effect of UV irradiation on aflatoxin reduction: a cytotoxicity evaluation study using human hepatoma cell line.
Patras A; Julakanti S; Yannam S; Bansode RR; Burns M; Vergne MJ
Mycotoxin Res; 2017 Nov; 33(4):343-350. PubMed ID: 28844113
[TBL] [Abstract][Full Text] [Related]
19. Quantification and validation of enzyme immunoassay for urinary aflatoxin B1-N7-guanine adduct for biological monitoring of aflatoxins.
Nayak S; Sashidhar RB; Bhat RV
Analyst; 2001 Feb; 126(2):179-83. PubMed ID: 11235100
[TBL] [Abstract][Full Text] [Related]
20. Long-term stability of human aflatoxin B1 albumin adducts assessed by isotope dilution mass spectrometry and high-performance liquid chromatography-fluorescence.
Scholl PF; Groopman JD
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1436-9. PubMed ID: 18559559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
